1. Home
  2. TYRA vs CLNE Comparison

TYRA vs CLNE Comparison

Compare TYRA & CLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TYRA
  • CLNE
  • Stock Information
  • Founded
  • TYRA 2018
  • CLNE 2001
  • Country
  • TYRA United States
  • CLNE United States
  • Employees
  • TYRA N/A
  • CLNE N/A
  • Industry
  • TYRA Biotechnology: Pharmaceutical Preparations
  • CLNE Natural Gas Distribution
  • Sector
  • TYRA Health Care
  • CLNE Utilities
  • Exchange
  • TYRA Nasdaq
  • CLNE Nasdaq
  • Market Cap
  • TYRA 556.4M
  • CLNE 610.0M
  • IPO Year
  • TYRA 2021
  • CLNE 2007
  • Fundamental
  • Price
  • TYRA $10.09
  • CLNE $1.60
  • Analyst Decision
  • TYRA Strong Buy
  • CLNE Strong Buy
  • Analyst Count
  • TYRA 6
  • CLNE 3
  • Target Price
  • TYRA $30.50
  • CLNE $4.33
  • AVG Volume (30 Days)
  • TYRA 281.8K
  • CLNE 2.0M
  • Earning Date
  • TYRA 05-08-2025
  • CLNE 05-08-2025
  • Dividend Yield
  • TYRA N/A
  • CLNE N/A
  • EPS Growth
  • TYRA N/A
  • CLNE N/A
  • EPS
  • TYRA N/A
  • CLNE N/A
  • Revenue
  • TYRA N/A
  • CLNE $415,920,000.00
  • Revenue This Year
  • TYRA N/A
  • CLNE N/A
  • Revenue Next Year
  • TYRA N/A
  • CLNE $11.70
  • P/E Ratio
  • TYRA N/A
  • CLNE N/A
  • Revenue Growth
  • TYRA N/A
  • CLNE 4.85
  • 52 Week Low
  • TYRA $6.42
  • CLNE $1.30
  • 52 Week High
  • TYRA $29.60
  • CLNE $3.67
  • Technical
  • Relative Strength Index (RSI)
  • TYRA 52.97
  • CLNE 52.79
  • Support Level
  • TYRA $8.80
  • CLNE $1.40
  • Resistance Level
  • TYRA $10.56
  • CLNE $1.60
  • Average True Range (ATR)
  • TYRA 0.75
  • CLNE 0.10
  • MACD
  • TYRA 0.06
  • CLNE 0.04
  • Stochastic Oscillator
  • TYRA 58.90
  • CLNE 56.18

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About CLNE Clean Energy Fuels Corp.

Clean Energy Fuels Corp is a natural gas marketer and retailer operating in the United States and Canada. The company supplies compressed natural gas, liquefied natural gas, and renewable natural gas as an alternative fuel for vehicles. The majority of revenue is generated within the U.S. and mostly consists of compressed natural gas. The company operates by purchasing natural gas from local utilities; compressing, cooling, or liquefying it at company-owned plants; and selling natural gas products through company-owned or customer-owned fueling stations. The company also builds, operates, and maintains natural gas fueling stations for customers. The company's target markets include heavy-duty trucking, airports, public transit, institutional energy users, and government fleets.

Share on Social Networks: